AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34609110 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (Douro Litoral)
Number of subjects: 961
Study 34609110 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (Trás‐os‐Montes and Alto Douro)
Number of subjects: 961
Study 33154177 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (GTN)
Number of subjects: 4011
Study 33154177 — intervention group
Group type: COMPARATOR
Intervention: Control (no GTN)
Number of subjects: 4011
Study 32559039 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancellous block allograft
Number of subjects: 20
Study 32559039 — intervention group
Group type: COMPARATOR
Intervention: Demineralized bone matrix (DBM) allograft
Number of subjects: 20
Study 35911508 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated team assessment
Number of subjects: 477
Study 35911508 — intervention group
Group type: COMPARATOR
Intervention: Real team assessment
Number of subjects: 477
Study 32568464 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg once daily
Number of subjects: 35
Study 32568464 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 33800428 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal Hypopressive Training (AHT) - 2 sessions of 30 min per week for 8 weeks
Number of subjects: 125
Study 33085123 — intervention group
Group type: EXPERIMENTAL
Intervention: DDDR pacing
Number of subjects: 1284
Study 33085123 — intervention group
Group type: COMPARATOR
Intervention: VVIR pacing
Number of subjects: 1284
Study 36180008 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 297
Study 36180008 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 297
Study 36180008 — intervention group
Group type: COMPARATOR
Intervention: Pain control beliefs
Number of subjects: 297
Study 36180008 — intervention group
Group type: COMPARATOR
Intervention: Lower anxiety
Number of subjects: 297
Study 33839801 — intervention group
Group type: EXPERIMENTAL
Intervention: Placental growth factor (PlGF) levels measured at baseline and at 24 and 34 weeks of gestation
Number of subjects: 157
Study 33839801 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy placenta (PlGF > 100) with suboptimal glycaemic control
Number of subjects: 157
Study 33839801 — intervention group
Group type: EXPERIMENTAL
Intervention: sFlt‐1/PlGF ratio as a marker for healthy vs unhealthy placenta
Number of subjects: 157
Study 32170961 — intervention group
Group type: EXPERIMENTAL
Intervention: hrHPV-positive women with positive high-grade squamous intraepithelial lesion (HSIL) cytology
Number of subjects: 1091
Study 32170961 — intervention group
Group type: EXPERIMENTAL
Intervention: hrHPV-positive women with positive low-grade squamous intraepithelial lesion (LSIL) cytology
Number of subjects: 1091
Study 32170961 — intervention group
Group type: EXPERIMENTAL
Intervention: hrHPV-positive women with positive atypical squamous cells of undetermined significance (ASC-US) cytology
Number of subjects: 1091
Study 32170961 — intervention group
Group type: EXPERIMENTAL
Intervention: hrHPV-positive women with p16 positive
Number of subjects: 1091
Study 32170961 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral of women positive for either p16 or LSIL+ cytology
Number of subjects: 1091
Study 32170961 — intervention group
Group type: EXPERIMENTAL
Intervention: hrHPV-positive women negative for both p16 and cytology (LSIL threshold)
Number of subjects: 1091
Study 32170961 — intervention group
Group type: EXPERIMENTAL
Intervention: hrHPV-positive women positive for either p16 or HPV16/33
Number of subjects: 1091
Study 35091184 — intervention group
Group type: EXPERIMENTAL
Intervention: Neo‐adjuvant radiotherapy (NART) before NACT
Number of subjects: 20
Study 35091184 — intervention group
Group type: COMPARATOR
Intervention: NACT and postoperative RT
Number of subjects: 20
Study 33640376 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakfast with a bitter espresso coffee and a whole wheat croissant
Number of subjects: 40
Study 33640376 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakfast with a bitter espresso coffee and a protein croissant
Number of subjects: 40
Study 33640376 — intervention group
Group type: COMPARATOR
Intervention: Whole wheat croissant
Number of subjects: 40
Study 33640376 — intervention group
Group type: COMPARATOR
Intervention: Protein croissant
Number of subjects: 40
Study 32622394 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory care (n=117)
Number of subjects: 236
Study 32622394 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n=119)
Number of subjects: 236
Study 35258240 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 33268341 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium/olodaterol (T/O)
Number of subjects: 76
Study 33268341 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate/salmeterol (F/S)
Number of subjects: 76
Study 36169918 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol and myoinositol (1000 mg each, twice daily for 12 weeks)
Number of subjects: 110
Study 36169918 — intervention group
Group type: COMPARATOR
Intervention: Metformin and pioglitazone (500 mg and 15 mg respectively, twice daily for 12 weeks)
Number of subjects: 110
Study 34119717 — intervention group
Group type: COMPARATOR
Intervention: Standard Prolonged Exposure (SPE; 10 weekly 90-min sessions)
Number of subjects: 135
Study 34119717 — intervention group
Group type: EXPERIMENTAL
Intervention: Massed Prolonged Exposure (MPE; 10 daily 90-min sessions)
Number of subjects: 135
Study 32222015 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (4 mg/kg)
Number of subjects: 18
Study 32222015 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 35393520 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer group with a high proportion of parents believing boys are innately better than girls at learning mathematics
Number of subjects: 0
Study 34698463 — intervention group
Group type: EXPERIMENTAL
Intervention: Xingnao Kaiqiao needling combined with respiratory training
Number of subjects: 124
Study 34698463 — intervention group
Group type: COMPARATOR
Intervention: Respiratory training (control group)
Number of subjects: 124
Study 34010418 — intervention group
Group type: EXPERIMENTAL
Intervention: Omission of axillary lymph node dissection
Number of subjects: 566
Study 34010418 — intervention group
Group type: EXPERIMENTAL
Intervention: Mastectomy without adjuvant radiotherapy
Number of subjects: 566
Study 34010418 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-conserving surgery
Number of subjects: 566
Study 34010418 — intervention group
Group type: EXPERIMENTAL
Intervention: Mastectomy
Number of subjects: 566
Study 32191766 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:2 dextrose solution (HYPO)
Number of subjects: 40
Study 32191766 — intervention group
Group type: COMPARATOR
Intervention: Hartmann's solution (ISO)
Number of subjects: 40
Study 33363447 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) with bioresorbable vascular scaffold (BVS) placement
Number of subjects: 34
Study 33363447 — intervention group
Group type: COMPARATOR
Intervention: Optimal medicinal therapy (OMT)
Number of subjects: 34
Study 35187941 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-exercises (TE) applied 3 days/week for 8 weeks
Number of subjects: 41
Study 35187941 — intervention group
Group type: COMPARATOR
Intervention: Tele-exercises + Nutritional Coaching (TE+NC) applied 3 days/week for TE and 1 day/week for NC for 8 weeks
Number of subjects: 41
Study 33409843 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrotherapy program based on McKenzie and Williams therapy, performed individually 3 days per week for 20 sessions.
Number of subjects: 28
Study 33409843 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 28
Study 34279777 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom-centered intervention (CC)
Number of subjects: 700
Study 34279777 — intervention group
Group type: EXPERIMENTAL
Intervention: Family school partnership (FSP) intervention
Number of subjects: 700
Study 34279777 — intervention group
Group type: COMPARATOR
Intervention: Business as usual (control group)
Number of subjects: 700
Study 34527335 — intervention group
Group type: EXPERIMENTAL
Intervention: New percutaneous positioning device combined with CNLB (n=75)
Number of subjects: 150
Study 34527335 — intervention group
Group type: COMPARATOR
Intervention: Standard CNLB (control, n=75)
Number of subjects: 150
Study 32316794 — intervention group
Group type: EXPERIMENTAL
Intervention: White noise CD
Number of subjects: 60
Study 32316794 — intervention group
Group type: COMPARATOR
Intervention: Control group (no white noise)
Number of subjects: 60
Study 32087610 — intervention group
Group type: EXPERIMENTAL
Intervention: LifeStories video self-help intervention based on acceptance and commitment therapy (ACT), used over a period of 4 weeks
Number of subjects: 40
Study 32087610 — intervention group
Group type: COMPARATOR
Intervention: Attention-matched comparison group (control)
Number of subjects: 40
Study 32087610 — intervention group
Group type: EXPERIMENTAL
Intervention: LifeStories video self-help intervention based on acceptance and commitment therapy (ACT)
Number of subjects: 40
Study 35979768 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical vertebra pulling therapy (once a week, 4 times total)
Number of subjects: 60
Study 35979768 — intervention group
Group type: COMPARATOR
Intervention: Sitting traction therapy (once a week, 4 times total)
Number of subjects: 60
Study 35979768 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical vertebra pulling therapy
Number of subjects: 60
Study 35979768 — intervention group
Group type: COMPARATOR
Intervention: Sitting traction therapy
Number of subjects: 60
Study 33663253 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle Guide (NG) technique
Number of subjects: 34
Study 33663253 — intervention group
Group type: COMPARATOR
Intervention: Free Hand (FH) technique
Number of subjects: 34
Study 32103635 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness programme delivered over 9 weeks by a Registered Nurse trained in mindfulness strategies.
Number of subjects: 140
Study 32103635 — intervention group
Group type: COMPARATOR
Intervention: Routine care as provided in the facilities, including routine check-ups at diabetes clinics.
Number of subjects: 140
Study 32103635 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness programme
Number of subjects: 140
Study 35181680 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary RT-LAMP assay
Number of subjects: 443
Study 35181680 — intervention group
Group type: COMPARATOR
Intervention: Nasopharyngeal (NP) swabs tested by RT-qPCR
Number of subjects: 443
Study 34311473 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Convolutional Neural Network (DCNN) using Med3D with data augmentation (DA) and global average pooling (GAP) techniques
Number of subjects: 159
Study 34311473 — intervention group
Group type: COMPARATOR
Intervention: Native DCNN without data augmentation or global average pooling
Number of subjects: 159
Study 35609488 — intervention group
Group type: EXPERIMENTAL
Intervention: μ‐Scan 2.0 automation system
Number of subjects: 1726
Study 35609488 — intervention group
Group type: COMPARATOR
Intervention: Manual smear microscopy
Number of subjects: 1726
Study 33074196 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy without head cover (Group A)
Number of subjects: 112
Study 33074196 — intervention group
Group type: COMPARATOR
Intervention: Phototherapy with head cover (Group B)
Number of subjects: 112
Study 32151249 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin prescription
Number of subjects: 500
Study 32151249 — intervention group
Group type: EXPERIMENTAL
Intervention: High baseline low-density lipoprotein cholesterol
Number of subjects: 500
Study 32151249 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing duration of diabetes
Number of subjects: 500
Study 32151249 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of chronic kidney disease
Number of subjects: 500
Study 36235868 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent fasting (16 hours fasting per day for three months)
Number of subjects: 30
Study 33770218 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet based on the Dietary Guidelines for Americans (DGA 2010)
Number of subjects: 44
Study 33770218 — intervention group
Group type: COMPARATOR
Intervention: Typical American diet (TAD)
Number of subjects: 44
Study 32081901 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan (NMDA receptor antagonist)
Number of subjects: 14
Study 32081901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 34404339 — intervention group
Group type: EXPERIMENTAL
Intervention: 50g xylitol
Number of subjects: 20
Study 34404339 — intervention group
Group type: EXPERIMENTAL
Intervention: 75g erythritol
Number of subjects: 20
Study 34404339 — intervention group
Group type: EXPERIMENTAL
Intervention: 75g glucose
Number of subjects: 20
Study 34404339 — intervention group
Group type: COMPARATOR
Intervention: 300mL tap water
Number of subjects: 20
Study 32023013 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene 0.045% lotion
Number of subjects: 268
Study 32023013 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 268
Study 33236240 — intervention group
Group type: COMPARATOR
Intervention: Group 1 (shorter root length)
Number of subjects: 28
Study 33236240 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (longer root length)
Number of subjects: 28
Study 33236240 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between DZ level and root/tooth length
Number of subjects: 28
Study 33236240 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between DZ thickness and distal groove depth
Number of subjects: 28
Study 33236240 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between DZ position and depth of mesial grooves
Number of subjects: 28
Study 33236240 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between DZ position and depth of distal grooves
Number of subjects: 28
Study 33236240 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between root length and distal groove depth
Number of subjects: 28
Study 33236240 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between orifice distance and mesial groove depth
Number of subjects: 28
Study 33301079 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term vitamin D supplementation
Number of subjects: 0
Study 33301079 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term n-3 fatty acid supplementation
Number of subjects: 0
Study 33301079 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo or no supplementation)
Number of subjects: 0
Study 34283004 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-weeks of the online metacognitive intervention (MCI)
Number of subjects: 108
Study 34283004 — intervention group
Group type: COMPARATOR
Intervention: Wait-list (WL)
Number of subjects: 108
Study 34797294 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture, 2 times a week for 12 weeks (total of 24 sessions)
Number of subjects: 50
Study 34797294 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture, 2 times a week for 12 weeks (total of 24 sessions)
Number of subjects: 50
Study 35339324 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 78
Study 35339324 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TXA)
Number of subjects: 78
Study 33333146 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity running exercise under hypoxia (fraction of inspired oxygen 14.5%)
Number of subjects: 21
Study 33333146 — intervention group
Group type: COMPARATOR
Intervention: High-intensity running exercise under normoxia (fraction of inspired oxygen 20.9%)
Number of subjects: 21
Study 33333146 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiography during stress
Number of subjects: 21
Study 33333146 — intervention group
Group type: COMPARATOR
Intervention: Echocardiography under hypoxia
Number of subjects: 21
Study 33954911 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg dexamethasone phosphate (DEX-P)
Number of subjects: 48
Study 33954911 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg betamethasone phosphate (BET-P)
Number of subjects: 48
Study 33954911 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:1 mixture of betamethasone phosphate and acetate (BET-PA)
Number of subjects: 48
Study 32236718 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant antiplatelet therapy (APT)
Number of subjects: 2199
Study 32236718 — intervention group
Group type: COMPARATOR
Intervention: No concomitant antiplatelet therapy (APT)
Number of subjects: 2199
Study 35414108 — intervention group
Group type: EXPERIMENTAL
Intervention: Double injection (DI) of local anesthetics (0.5% ropivacaine 24 mL)
Number of subjects: 86
Study 35414108 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple injection (TI) of local anesthetics (0.5% ropivacaine 24 mL)
Number of subjects: 86
Study 34792926 — intervention group
Group type: EXPERIMENTAL
Intervention: Education and counseling program on preeclampsia
Number of subjects: 132
Study 34792926 — intervention group
Group type: COMPARATOR
Intervention: Standard prenatal care
Number of subjects: 132
Study 33390056 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (Mtx)
Number of subjects: 30
Study 33390056 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate plus intramuscular vitamin D (MtxD)
Number of subjects: 30
Study 33390056 — intervention group
Group type: COMPARATOR
Intervention: Control group (Methotrexate alone)
Number of subjects: 30
Study 33390056 — intervention group
Group type: EXPERIMENTAL
Intervention: Control group (Methotrexate plus vitamin D)
Number of subjects: 30
Study 33340522 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (40 IU)
Number of subjects: 26
Study 33340522 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 33340522 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher anti-dopaminergic medication dosage
Number of subjects: 26
Study 35099998 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient therapy without antibiotics
Number of subjects: 0
Study 35099998 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics
Number of subjects: 0
Study 34931999 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐cigarettes are as harmful or more harmful than smoking
Number of subjects: 2400
Study 34931999 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐cigarettes are completely harmless
Number of subjects: 2400
Study 34931999 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncertainty about e‐cigarette harms
Number of subjects: 2400
Study 34931999 — intervention group
Group type: COMPARATOR
Intervention: Control (physical activity)
Number of subjects: 2400
Study 36293136 — intervention group
Group type: EXPERIMENTAL
Intervention: Microencapsulated ferric saccharate (MFS) 60 mg/day for 14 days
Number of subjects: 0
Study 36293136 — intervention group
Group type: COMPARATOR
Intervention: Ferrous sulphate (FS) 60 mg/day for 14 days
Number of subjects: 0
Study 34172613 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS
Number of subjects: 30
Study 34172613 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 36380013 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium-glucose cotransporter-2 inhibitors (SGLT2i)
Number of subjects: 380
Study 32985145 — intervention group
Group type: EXPERIMENTAL
Intervention: New Pulse Shape 1 (NPS1)
Number of subjects: 145
Study 32985145 — intervention group
Group type: EXPERIMENTAL
Intervention: New Pulse Shape 2 (NPS2)
Number of subjects: 145
Study 32985145 — intervention group
Group type: COMPARATOR
Intervention: Standard Pulse Shape (SPS)
Number of subjects: 145
Study 35891482 — intervention group
Group type: EXPERIMENTAL
Intervention: WEVEE VRP vaccine (two doses, administered 28 days apart)
Number of subjects: 33
Study 35891482 — intervention group
Group type: COMPARATOR
Intervention: Control group (11 NHPs)
Number of subjects: 33
Study 33975865 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescription sleep medications
Number of subjects: 238
Study 33975865 — intervention group
Group type: COMPARATOR
Intervention: Non-users of prescription sleep medications
Number of subjects: 238
Study 32371767 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive SBP goal of less than 120mmHg
Number of subjects: 5385
Study 36401416 — intervention group
Group type: EXPERIMENTAL
Intervention: Trocar needle
Number of subjects: 503
Study 36401416 — intervention group
Group type: COMPARATOR
Intervention: Steel needle
Number of subjects: 503
Study 35879528 — intervention group
Group type: EXPERIMENTAL
Intervention: Palaeolithic diet
Number of subjects: 70
Study 35879528 — intervention group
Group type: COMPARATOR
Intervention: Control low‐fat diet
Number of subjects: 70
Study 34747368 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (7 monthly doses)
Number of subjects: 0
Study 34747368 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32132641 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced bedtime variability (n=29)
Number of subjects: 37
Study 32132641 — intervention group
Group type: COMPARATOR
Intervention: Increased/maintained bedtime variability (n=8)
Number of subjects: 37
Study 36605335 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 20
Study 36605335 — intervention group
Group type: COMPARATOR
Intervention: Non-PRP
Number of subjects: 20
Study 33037681 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-minute infusion of vincristine (VCR)
Number of subjects: 429
Study 33037681 — intervention group
Group type: COMPARATOR
Intervention: 3-hour infusion of vincristine (VCR)
Number of subjects: 429
Study 33037681 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracellular VCR24h levels in B-ALL patients
Number of subjects: 429
Study 33037681 — intervention group
Group type: EXPERIMENTAL
Intervention: ABCB1 genotype 2677GG
Number of subjects: 429
Study 32544361 — intervention group
Group type: EXPERIMENTAL
Intervention: bivalent HPV‐16/18 vaccine with a 1st interval of 28–40 d and a 2nd interval of 140–160 d
Number of subjects: 3689
Study 32544361 — intervention group
Group type: EXPERIMENTAL
Intervention: bivalent HPV‐16/18 vaccine with a 1st interval of 41–50 d
Number of subjects: 3689
Study 32544361 — intervention group
Group type: EXPERIMENTAL
Intervention: bivalent HPV‐16/18 vaccine with a 1st interval of 51–60 d
Number of subjects: 3689